Letter to the editor: A reminder to screen for varices! Atezolizumab/bevacizumab for HCC
Kelly Suchman, Ben L. Da – 2 May 2022
Another important step toward a prophylactic vaccine against hepatitis C
Christoph Neumann‐Haefelin, Robert Thimme – 2 May 2022
Reply
Antonio D’Alessio, Claudia Angela Maria Fulgenzi, David J. Pinato – 2 May 2022
Letter to the editor: Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study—Should we extend the boundaries?
Parakh Gulati, Sunil Taneja, Ajay Duseja, Virendra Singh – 2 May 2022
Skeletal muscle mass to visceral fat area ratio as a predictor of NAFLD in lean and overweight men and women with effect modification by sex
Yoosun Cho, Yoosoo Chang, Seungho Ryu, Hyun‐Suk Jung, Chan‐won Kim, Hyungseok Oh, Mi Kyung Kim, Won Sohn, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne – 2 May 2022 – The effect of sarcopenic visceral obesity on the risk of nonalcoholic fatty liver disease (NAFLD) is uncertain. We investigated (a) whether the skeletal muscle mass to visceral fat area ratio (SV ratio), as a measure of sarcopenic visceral obesity, is a risk factor for NAFLD; and (b) whether the SV ratio adds to conventional adiposity measures to improve prediction of incident NAFLD.
Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register study
Ann‐Sofi Duberg, Charlotte Lybeck, Anna Fält, Scott Montgomery, Soo Aleman – 2 May 2022 – Chronic hepatitis B virus (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC), and surveillance is recommended for patients without cirrhosis when risk exceeds an incidence rate (IR) of 0.2%. Populations in Asia and sub‐Saharan Africa have been associated with HCC at younger ages, but the risk after immigration to Western countries should be investigated. The aim of this study was to study HCC by age and country of origin in people with chronic HBV infection in Sweden.
NAFLD polygenic risk score and risk of hepatocellular carcinoma in an East Asian population
Claire E. Thomas, Brenda Diergaarde, Allison L. Kuipers, Jennifer J. Adibi, Hung N. Luu, Xuling Chang, Rajkumar Dorajoo, Chew‐Kiat Heng, Chiea‐Chuen Khor, Renwei Wang, Aizhen Jin, Woon‐Puay Koh, Jian‐Min Yuan – 2 May 2022 – It is difficult to identify people with nonalcoholic fatty liver disease (NAFLD) who are at high risk for developing hepatocellular carcinoma (HCC). A polygenic risk score (PRS) for hepatic fat (HFC‐PRS) derived from non‐Asians has been reported to be associated with HCC risk in European populations.
Patient Resources
It’s important to be able to communicate with patients effectively and AASLD has created resources to help you do that. See the growing list of tools at your disposal to print and deliver as you need.
Clinician Resources
AASLD offers a variety of resources for hepatologists and other clinicians. These resources are available to enhance knowledge and improve quality care in the hepatology field. Every resource is curated with the audience in mind and complimentary access is granted with an AASLD membership.
Hepatology Training Pathways
By achieving American Board of Internal Medicine (ABIM) and/or American Board of Pediatric (ABP) certification in transplant hepatology, you demonstrate your commitment to the profession and show the public, your patients, your institution, and your colleagues that you have attained expertise in advanced and transplant hepatology beyond the general hepatology competence expected of a gastroenterologist.